Treatment of metastatic melanoma with combined chemotherapy containing cisplatin, vinblastine and dacarbazine (CVD) and biotherapy using interleukin-2 and interferon-alpha.
暂无分享,去创建一个
A. Buzaid | S. Legha | A. Bedikian | O. Eton | N. Papadopoulos | S. Ring | C. Plager
[1] R. Fisher,et al. Multiinstitutional phase II trial of intensive combination chemoimmunotherapy for metastatic melanoma. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] P. Queirolo,et al. Multicenter randomized trial of dacarbazine alone or in combination with two different doses and schedules of interferon alfa-2a in the treatment of advanced melanoma. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] S. Rosenberg,et al. Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin 2. , 1994, JAMA.
[4] C. Borel,et al. Sequential chemoimmunotherapy with cisplatin, interleukin-2, and interferon alfa-2a for metastatic melanoma. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] R. Fisher,et al. Randomized phase III trial of treatment with high-dose interleukin-2 either alone or in combination with interferon alfa-2a in patients with advanced melanoma. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] C. Scheibenbogen,et al. Interferon‐α and interleukin‐2 in the treatment of metastatic melanoma. Comparison of two phase II trials , 1993 .
[7] S. Martino,et al. A phase II study of dacarbazine and cisplatin in combination with outpatient administered interleukin‐2 in metastatic malignant melanoma , 1993, Cancer.
[8] R. Dillman,et al. Inpatient continuous‐infusion interleukin‐2 in 788 patients with cancer the national biotherapy study group experience , 1993, Cancer.
[9] M. Citron,et al. A phase II trial of concomitant human interleukin-2 and interferon-alpha-2a in patients with disseminated malignant melanoma. , 1993, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.
[10] J. Richards,et al. Sequential chemoimmunotherapy in the treatment of metastatic melanoma. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] D. Berd,et al. Effective combination chemo/hormonal therapy for malignant melanoma: Experience with three consecutive trials , 1992, International journal of cancer.
[12] M. Atkins,et al. Interleukin-2 and high-dose cisplatin in patients with metastatic melanoma: a pilot study. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] J. Richards,et al. Sequential chemoimmunotherapy for metastatic melanoma. , 1991, Seminars in oncology.
[14] J. Doroshow,et al. Interleukin-2 therapy in patients with metastatic malignant melanoma: a phase II study. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] S. Martino,et al. A phase I‐II study of dacarbazine in combination with outpatient interleukin‐2 in metastatic malignant melanoma , 1990, Cancer.
[16] S. Steinberg,et al. Combination therapy with interleukin-2 and alpha-interferon for the treatment of patients with advanced cancer. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] R. Benjamin,et al. A prospective evaluation of a triple‐drug regimen containing cisplatin, vinblastine, and dacarbazine (CVD) for metastatic melanoma , 1989, Cancer.
[18] J. Murray,et al. Concomitant administration of recombinant human interleukin-2 and recombinant interferon alpha-2A in cancer patients: a phase I study. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] R. Benjamin,et al. Clinical evaluation of recombinant interferon alfa-2a (Roferon-A) in metastatic melanoma using two different schedules . , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] D. Ahmann,et al. Recombinant leukocyte a interferon (rIFN‐αA) in the treatment of disseminated malignant melanoma: Analysis of complete and long‐term responding patients , 1986, Cancer.
[21] S. Legha. Interferons in the treatment of malignant melanoma. A review of recent trials , 1986, Cancer.
[22] C. Scheibenbogen,et al. Interferon-alpha and interleukin-2 in the treatment of metastatic melanoma. Comparison of two phase II trials. , 1993, Cancer.